 |
PDBsum entry 1tkt
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
Chains A, B:
E.C.2.7.7.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains A, B:
E.C.2.7.7.49
- RNA-directed Dna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
DNA(n)
|
+
|
2'-deoxyribonucleoside 5'-triphosphate
|
=
|
DNA(n+1)
Bound ligand (Het Group name = )
matches with 55.56% similarity
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chains A, B:
E.C.2.7.7.7
- DNA-directed Dna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
DNA(n)
|
+
|
2'-deoxyribonucleoside 5'-triphosphate
|
=
|
DNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
Chains A, B:
E.C.3.1.-.-
|
|
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
Chains A, B:
E.C.3.1.13.2
- exoribonuclease H.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Exonucleolytic cleavage to 5'-phosphomonoester oligonucleotides in both 5'- to 3'- and 3'- to 5'-directions.
|
 |
 |
 |
 |
 |
Enzyme class 6:
|
 |
Chains A, B:
E.C.3.1.26.13
- retroviral ribonuclease H.
|
|
 |
 |
 |
 |
 |
Enzyme class 7:
|
 |
Chains A, B:
E.C.3.4.23.16
- HIV-1 retropepsin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Specific for a P1 residue that is hydrophobic, and P1' variable, but often Pro.
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Med Chem
47:5912-5922
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
|
|
A.L.Hopkins,
J.Ren,
J.Milton,
R.J.Hazen,
J.H.Chan,
D.I.Stuart,
D.K.Stammers.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We have used a structure-based approach to design a novel series of
non-nucleoside inhibitors of HIV-1 RT (NNRTIs). Detailed analysis of a wide
range of crystal structures of HIV-1 RT-NNRTI complexes together with data on
drug resistance mutations has identified factors important for tight binding of
inhibitors and resilience to mutations. Using this approach we have designed and
synthesized a novel series of quinolone NNRTIs. Crystal structure analysis of
four of these compounds in complexes with HIV-1 RT confirms the predicted
binding modes. Members of this quinolone series retain high activity against the
important resistance mutations in RT at Tyr181Cys and Leu100Ile.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.M.Doolittle,
and
S.M.Gomez
(2010).
Structural similarity-based predictions of protein interactions between HIV-1 and Homo sapiens.
|
| |
Virol J,
7,
82.
|
 |
|
|
|
|
 |
Z.K.Sweeney,
J.J.Kennedy-Smith,
J.Wu,
N.Arora,
J.R.Billedeau,
J.P.Davidson,
J.Fretland,
J.Q.Hang,
G.M.Heilek,
S.F.Harris,
D.Hirschfeld,
P.Inbar,
H.Javanbakht,
J.A.Jernelius,
Q.Jin,
Y.Li,
W.Liang,
R.Roetz,
K.Sarma,
M.Smith,
D.Stefanidis,
G.Su,
J.M.Suh,
A.G.Villaseñor,
M.Welch,
F.J.Zhang,
and
K.Klumpp
(2009).
Diphenyl ether non-nucleoside reverse transcriptase inhibitors with excellent potency against resistant mutant viruses and promising pharmacokinetic properties.
|
| |
ChemMedChem,
4,
88-99.
|
 |
|
|
|
|
 |
A.L.Hopkins
(2008).
Network pharmacology: the next paradigm in drug discovery.
|
| |
Nat Chem Biol,
4,
682-690.
|
 |
|
|
|
|
 |
X.Zhang,
A.Crespo,
and
A.Fernández
(2008).
Turning promiscuous kinase inhibitors into safer drugs.
|
| |
Trends Biotechnol,
26,
295-301.
|
 |
|
|
|
|
 |
Y.Wang,
F.E.Chen,
J.Balzarini,
E.De Clercq,
and
C.Pannecouque
(2008).
Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
|
| |
Chem Biodivers,
5,
168-176.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |
|